Log In
Print this Print this

CancerTYPE ID test

Also known as: formerly Theros CancerTYPE ID

  Manage Alerts
Collapse Summary General Information
Company bioMerieux S.A.
DescriptionMolecular cancer classification assay based on expression of 92 genes
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose carcinoma of unknown primary origin as directed by molecular profiling; Predict cancer origin
Regulatory Designation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today